Removal of Hepatitis C Virus in the Serum of Chimpanzees by Phasmapheresis
采血法去除黑猩猩血清中的丙型肝炎病毒
基本信息
- 批准号:10557054
- 负责人:
- 金额:$ 3.33万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hepatitis C virus (HCV) particles in the serum of hepatitis C patients can be separated into the two fractions according to their density, heavy fraction and light fraction. The former is present with the binding immunoglobulin. We have reported that a higher ratio of the light and the heavy fractions corresponds to the better response rate against interferon therapy. The results indicate that removal of the immunoglobulin-binding fraction may help better response against interferon therapy.Not only present status of HCV in the serum of chronic hepatitis C patients, but in the liver tissues were studied. Different species of HCV were present in the liver, and the quasispecies of HCV was increased with the severity of liver disease as if the liver consits of a compartment. These results are helpful for the understanding of HCV virology and physiology of this plasma-pheresis study.Thus, we made several columns for the usage of plasmapheresis which remove immunoglobulin in the serum of chronic hepatitis C patients. The absorption rate with appropriate flow and column volumes was studied by a batch test and a mini-column apparatus, and the best column reagents was chosen.Two chimpanzees infected with HCV were plasmapheresed using the best reagents in an animal facility. The procedure was finished with safe in terms of circulation, respiration, renal function. Biochemical changes were transient, and there were no infection after the procedure. However, due to anticoagulant used, bleeding at the site of catheterization was found. Serial changes of HCV in the serum and liver tissue were demonstrated in the chimpanzees.
丙型肝炎患者血清中的丙型肝炎病毒(HCV)颗粒按其密度可分为两个组分,即重组分和轻组分。前者与结合免疫球蛋白一起存在。我们已经报道了更高的轻组分和重组分的比例对应于对干扰素治疗的更好的应答率。结果表明,去除免疫球蛋白结合部分可能有助于更好地对干扰素治疗的反应。不仅在慢性丙型肝炎患者的血清中,但在肝组织中的HCV的存在状态进行了研究。肝内存在不同种类的HCV,且准种随肝病的加重而增多,似乎肝是一个分隔区。这些结果有助于理解HCV病毒学和本血浆置换研究的生理学。因此,我们制作了几种用于血浆置换的柱,以去除慢性丙型肝炎患者血清中的免疫球蛋白。通过批试验和微型柱装置研究了适宜流速和柱体积下的血浆吸附速率,筛选出最佳柱试剂,并在动物实验室用最佳柱试剂对2只感染HCV的黑猩猩进行了血浆分离。手术在循环、呼吸、肾功能方面安全完成。生化变化是短暂的,手术后没有感染。但由于使用了抗凝剂,导致置管部位出血,血清和肝组织中HCV含量发生了一系列变化。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hideki Ohono: "Human hepatitis B virus X protein augments the DNA binding of NF-IL6 through its basic-leucine zipper domain"Journal of Medical Virology. 58. 11-18 (1999)
Hideki Ohono:“人类乙型肝炎病毒 X 蛋白通过其碱性亮氨酸拉链结构域增强了 NF-IL6 的 DNA 结合”《医学病毒学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takayoshi Koura: "Investigation of albumin-synthesizing ability in rat cirrhotic liver-directed hepatocytes using primary hepatocyte culture"Journal of Hepatology. 31. 293-299 (1999)
Takayoshi Koura:“使用原代肝细胞培养物研究大鼠肝硬化肝定向肝细胞的白蛋白合成能力”肝脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takayoshi Koura: "Investigation of albumin-synthesizing ability in rat cirrhotic liver-directed hepatocytes primary hepatocyte culture"Journal of Hepatology. 31. 293-299 (1999)
Takayoshi Koura:“大鼠肝硬化肝定向肝细胞原代肝细胞培养物中白蛋白合成能力的研究”肝脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Katsuro Koike: "Survey of hepatitis B virus co-infection in hepatitis C virus infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan"Japanese Journal of Cancer Research. 90. 1270-1272 (1999)
小池胜郎:“日本慢性肝炎和肝细胞癌丙型肝炎病毒感染者中乙型肝炎病毒合并感染的调查”日本癌症研究杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Akito Sakai: "Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis"Hepatology. 30. 556-561 (1999)
Akito Sakai:“慢性肝炎患者血清和肝脏三个不同部位中丙型肝炎病毒的准种”肝病学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANEKO Shuichi其他文献
KANEKO Shuichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KANEKO Shuichi', 18)}}的其他基金
Study of the liver as an endocrine organ
肝脏作为内分泌器官的研究
- 批准号:
26253046 - 财政年份:2014
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Liver producing hormones and life style related diseases
肝脏产生激素和生活方式相关疾病
- 批准号:
23249042 - 财政年份:2011
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A fundamental study of diplomatic documents from 8th to 10th century in East Asia
8至10世纪东亚外交文献基础研究
- 批准号:
23520875 - 财政年份:2011
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Disturbance of hepatic function and over nutrition-related diseases
肝功能障碍和过度营养相关疾病
- 批准号:
18109008 - 财政年份:2006
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Establishment of Genomics Based Hepatology
基于基因组学的肝病学建立
- 批准号:
13854015 - 财政年份:2001
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Development of Biosensor-type-DNA Chip for the Diagnosis of Cancer
开发用于癌症诊断的生物传感器型DNA芯片
- 批准号:
11794017 - 财政年份:1999
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for University and Society Collaboration
Establishment of Gene Therapy for Advanced Hepatocellular Carcinoma with Intra- and Extra- Hepatic Metastases
晚期肝细胞癌肝内、肝外转移基因治疗的建立
- 批准号:
10470132 - 财政年份:1998
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Gene Therapy for Advanced Hepatocellular Carcinoma using Transcriptional Control
使用转录控制治疗晚期肝细胞癌的基因疗法
- 批准号:
08670571 - 财政年份:1996
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
第13届加拿大丙型肝炎病毒研讨会(CSHCV)
- 批准号:
487828 - 财政年份:2023
- 资助金额:
$ 3.33万 - 项目类别:
Miscellaneous Programs
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
- 批准号:
478700 - 财政年份:2023
- 资助金额:
$ 3.33万 - 项目类别:
Operating Grants
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
治愈之后:衡量直接作用抗病毒药物对加拿大艾滋病毒/丙型肝炎病毒合并感染者的全面影响
- 批准号:
469805 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
Operating Grants
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
- 批准号:
10449670 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure
简单的家庭测试,可快速、准确地筛查丙型肝炎病毒 (HCV) 暴露
- 批准号:
10709130 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒(HCV)感染的受控人类感染模型(CHIM)开发研讨会
- 批准号:
460792 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
Miscellaneous Programs
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus
丙型肝炎病毒的快速护理点诊断
- 批准号:
10683045 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
- 批准号:
10620846 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
直接作用抗病毒药物预防丙型肝炎病毒感染供者肾移植至未感染受者的随机对照试验 (PREVENT-HCV)
- 批准号:
10597168 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
- 批准号:
472508 - 财政年份:2022
- 资助金额:
$ 3.33万 - 项目类别:
Operating Grants














{{item.name}}会员




